2008 Nexus Award winners revealed

Share this article:
The Association of Medical Media (AMM) has announced the winners of the 2008 Nexus Awards. Sales representative Christine Miller, of The New England Journal of Medicine, was presented with the award for multi-specialty, while Chad Holloway, of Quadrant HealthCom's Neurology Reviews, won the award for single specialty.

“The AMM Nexus Awards represent those who exemplify the qualities of outstanding sales professionals, including superior service, professionalism and communication of ideas,” said MaryBeth Kurland, executive director, AMM. “By setting an industry standard, we hope to inspire others and reinforce the value of journal advertising.”

Recipients of the award were chosen by email ballots sent to an “industry-wide list of healthcare advertising decision makers,” according to Kurland. “Franklin Communications provided oversight of the voting process by implementing stringent quality control measures to ensure a high level of voter participation. 

A panel of independent industry leaders reviewed a blinded list   of top nominees in each category to determine the finalists. The identity of the winners remains a secret until announced at the luncheon.” 
Awards were presented during a gala luncheon at the Plaza Hotel in New York City. More than 200 AMM members and associates were in attendance. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?